Coeptis Therapeutics (COEP) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

COEP Coeptis Therapeutics

Watchlist

0.205
-0.034-14.19%

Trading Dec 4 13:55 ET

8.41MMarket Cap-730P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Coeptis Therapeutics to Acquire NexGenAI Affiliates Network
TipRanksDec 3 08:21 ET
Express News | Coeptis Therapeutics Executes Binding Letter of Intent to Acquire AI-Powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
ReutersDec 3 08:15 ET
Press Release: Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
Dow JonesDec 3 08:15 ET
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
Coeptis TherapeuticsDec 3 00:00 ET
10-Q: Q3 2024 Earnings Report
SECNov 13 16:48 ET · Announcements
Express News | Coeptis Therapeutics Announces Phase 1 Data on Dvx201 for Covid-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development
ReutersNov 7 08:07 ET

Comments

Jaguar8

20 hours ago

🟢Watchlist Wednesday, December 4. NFA. Check on my previous watchlist. Those without ✅ means they can have delayed market reaction.

Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...

Jaguar8

Dec 3 07:16

NEWS

$Coeptis Therapeutics (COEP.US)$
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
1 minute ago, 5:15 AM PST
Via PR Newswire
The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth
WEXFORD, Pa. , Dec. 3, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"...

Trytosaveabit

Dec 3 07:16

News

$Coeptis Therapeutics (COEP.US)$ Press Release: Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
Dow Jones· just

Trytosaveabit

Nov 7 07:08

Update

$Coeptis Therapeutics (COEP.US)$ Reuters· just
Coeptis Therapeutics Announces Phase 1 Data on Dvx201 for Covid-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

Jaguar8

Nov 7 07:07

NEWS

$Coeptis Therapeutics (COEP.US)$
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Developmen
Coeptis Therapeutics announced the acceptance of Phase 1 study results for DVX201, an allogeneic natural killer (NK) cell therapy, in Molecular Therapy Methods and Clinical Development. The study evaluated DVX201 for treating hospitalized COVID-19 patients at high risk for disease progression. Key f...

Heat List

Overall

No Data

Investment Theme

Top Gainers Yesterday

Intraday-1.07%